Impact Factor
3.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.32
1,526 total citations
h5-index
38
h5 depth signal
Cited share
84.5%
299 of 354
Total citations
1,526
Citation footprint
Metric signal
4.86
External metric anchor
Self-citation
3.4%
52 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
518
United States
396
India
319
Italy
115
United Kingdom
115
Citing Fields of Research
Drug Delivery Systems
997
Nanoparticles
842
Polymer & Macromolecule Science
296
Oncology
163
Immunology
157
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,726
Articles tracked across the journal lifetime
Indexed publication set
354
299 cited publications
Last 12 months
193
16.1 publications/month
Open access share
13.0%
25 OA publications in the last year
Leading citing country
China
518 citing publications
Leading citing field
Drug Delivery Systems
997 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Aug 2006-
v1n1, Aug 2006-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Nanoparticles
Polymer & Macromolecule Science
Immunology
Broad Categories
Nanotechnology
Nanoparticles
Drug Delivery Systems
Polymer & Macromolecule Science
MeSH Descriptors
Nanomedicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17435889.2026.2749660
Open DOI
Porous nanofibrous microspheres: synthesis approaches and applications to tissue regeneration
02
DOI 10.1080/17435889.2026.2749655
Open DOI
The role of nanomedicine in infectious diseases of the central nervous system: a narrative review
03
04
DOI 10.1080/17435889.2026.2744280
Open DOI
mRNA-based nanomedicine for diabetic wound repair: advances in LNP delivery, immune modulation, and regenerative pathways
05
06
DOI 10.1080/17435889.2026.2742413
Open DOI
Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapy
07
08
DOI 10.1080/17435889.2026.2741200
Open DOI
New approach methodologies to model the female reproductive tract: advances and opportunities for nanomedicine
09
DOI 10.1080/17435889.2026.2739511
Open DOI
Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer
1. Chemotherapy resistance is an important factor for treatment failure and disease progression of breast cancer (BC) patients. In order to achieve maximum therapeutic effect and minimal adverse ef...
10
DOI 10.1080/17435889.2026.2738705
Open DOI
Sensitizing nanomedicine for platinum-resistant ovarian cancer
1. Ovarian cancer (OC) is the most lethal gynecologic cancer globally, with a 5-year survival rate of 36–51% [1,2]. There are numerous histological subtypes of OC, with the most common histology be...
Bibliographical & Catalog Notes
Title from cover
Latest issue consulted: Vol. 2, no. 2 (Apr. 2007).
Also issued online.